Review
Nature Reviews Drug Discovery 1, 710-726 (September 2002) | doi:10.1038/nrd897
There is a Correction (1 November 2002) associated with this article.
Pharmacotherapy of addictions
Mary Jeanne Kreek1, K. Steven LaForge1 & Eduardo Butelman1 About the authors
Abstract
Addiction to drugs, such as heroin, cocaine and alcohol, exacts great human and financial costs on society, but the development of pharmacotherapies for addiction has been largely neglected by the pharmaceutical industry. With advances in our understanding of the underlying biology of addictions now opening the door for the development of novel pharmacotherapies, it could be time for a reassessment of involvement in this increasingly important therapeutic area. Here, we summarize the current approved and implemented pharmacotherapeutic approaches to the treatment of addiction, and then highlight the most promising areas for future drug development from the perspective of our laboratory and our National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) Research Center.
- View At a Glance
Author affiliations
- Laboratory of the Biology of Addictive Diseases, Rockefeller University, 1230 York Avenue, New York, New York 10021, USA.
Correspondence to: Mary Jeanne Kreek1 Email: kreek@mail.rockefeller.edu
|
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated REFERENCE NEWS AND VIEWS RESEARCH |
